Literature DB >> 19540702

Scaling-up interim methadone maintenance: treatment for 1,000 heroin-addicted individuals.

Robert P Schwartz1, Jerome H Jaffe, Kevin E O'Grady, Babita Das, David A Highfield, Monique E Wilson.   

Abstract

The objectives of this study were to determine the following: (a) the feasibility of expanding interim methadone treatment (IM), (b) the impact of IM on heroin and cocaine use, and (c) the effect of charging a modest fee for IM. Six clinics provided daily methadone plus emergency counseling only (IM) to heroin-addicted individuals on a waiting list for treatment. IM was provided for up to 120 days before transfer to regular methadone treatment. Drug testing was conducted at admission to IM and at transfer to methadone treatment program (MTP). Half the patients were charged $10/week for IM. Logistic regression analysis was used to determine the effect of fee status and other variables on transfer. Of 1,000 patients enrolled in IM, 762 patients (76.2%) were admitted to a regular MTP. For those who transferred (n = 762), opioid-positive tests decreased from 89.6% to 38.4%; cocaine, from 49.9% to 44.9% from admission to transfer. Logistic regression analysis indicated that fee status at baseline was not significantly associated with transfer. When limited public resources create waiting lists, IM can allow additional patients to sharply reduce heroin use while waiting for admission to MTP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540702      PMCID: PMC2796977          DOI: 10.1016/j.jsat.2009.04.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  18 in total

1.  Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment.

Authors:  G E Woody; A Muñoz
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Interim methadone clinics: an undervalued approach.

Authors:  V P Dole
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

3.  A randomized trial of an interim methadone maintenance clinic.

Authors:  S R Yancovitz; D C Des Jarlais; N P Peyser; E Drew; P Friedmann; H L Trigg; J W Robinson
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

4.  A controlled trial of buprenorphine treatment for opioid dependence.

Authors:  R E Johnson; J H Jaffe; P J Fudala
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

5.  Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.

Authors:  M Gossop; J Marsden; D Stewart; P Lehmann; J Strang
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

6.  Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome.

Authors:  D A Calsyn; E A Wells; A J Saxon; T R Jackson; A F Wrede; V Stanton; C Fleming
Journal:  J Addict Dis       Date:  1994

7.  Psychotherapy in community methadone programs: a validation study.

Authors:  G E Woody; A T McLellan; L Luborsky; C P O'Brien
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

8.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

9.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

Authors:  D S Metzger; G E Woody; A T McLellan; C P O'Brien; P Druley; H Navaline; D DePhilippis; P Stolley; E Abrutyn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-09

10.  The effects of psychosocial services in substance abuse treatment.

Authors:  A T McLellan; I O Arndt; D S Metzger; G E Woody; C P O'Brien
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

View more
  9 in total

1.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

2.  Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.

Authors:  Peter D Friedmann; Randall Hoskinson; Michael Gordon; Robert Schwartz; Timothy Kinlock; Kevin Knight; Patrick M Flynn; Wayne N Welsh; Lynda A R Stein; Stanley Sacks; Daniel J O'Connell; Hannah K Knudsen; Michael S Shafer; Elizabeth Hall; Linda K Frisman
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

3.  Commentary on "The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible".

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz
Journal:  J Addict Med       Date:  2018 Nov/Dec       Impact factor: 3.702

4.  Interim methadone treatment compared to standard methadone treatment: 4-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-02-24

5.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

6.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

7.  Within-subject evaluation of interim buprenorphine treatment during waitlist delays.

Authors:  Tatum N Oleskowicz; Taylor A Ochalek; Kelly R Peck; Gary J Badger; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2021-01-20       Impact factor: 4.492

8.  Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study.

Authors:  A Håkansson; C Widinghoff; T Abrahamsson; C Gedeon
Journal:  J Addict       Date:  2016-01-21

9.  A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol.

Authors:  Peter D Friedmann; Lori J Ducharme; Wayne Welsh; Linda Frisman; Kevin Knight; Timothy Kinlock; Shannon Gwin Mitchell; Elizabeth Hall; Terry Urbine; Michael Gordon; Sami Abdel-Salam; Dan O'Connell; Carmen Albizu-Garcia; Hannah Knudsen; Jamieson Duval; Juliane Fenster
Journal:  Health Justice       Date:  2013-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.